BRIEF-Pacira Announces FDA Approval Of Supplemental New Drug Application For Exparel As A Nerve Block To Produce Regional Analgesia
April 06, 2018 at 17:42 PM EDT
* PACIRA ANNOUNCES FDA APPROVAL OF SUPPLEMENTAL NEW DRUG APPLICATION FOR EXPAREL® AS A NERVE BLOCK TO PRODUCE REGIONAL ANALGESIA Source text for Eikon: Further company coverage:
